Fitbit has completed clinical trials of its own ECG feature and is looking to get FDA approval – as it launches a large scale study into Afib and irregular heart rate detection. The mass Fitbit Heart ...
HeartBeam (NASDAQ: BEAT) announced the initiation of a pilot study evaluating its investigational on-demand 12-lead ECG ...
USA: Researchers have discovered in a new study that an AI-based electrocardiogram (AI-ECG) algorithm demonstrated strong ...
GlobalData on MSN
HeartBeam commences pilot study of new 12-lead ECG patch
The study will enrol around 50 high-risk coronary artery disease patients whose resting ECGs show no signs of ischemia.
(NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, ...
The company’s 3D ECG technology captures the electrical signals of the heart from three non-coplanar directions. Credit: Natali _ Mis / Shutterstock. · Medical Device Network · Natali _ Mis / ...
Even minor ECG abnormalities detected with annual checks signal a greater risk of future CVD events, a study of several million working-age people affirms, although questions remain about whether ...
Please provide your email address to receive an email when new articles are posted on . Abnormal ECG findings were rare in elite female basketball players. These data may serve as a reference for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results